Semax: Benefits, Dosage, Side Effects, and How to Get It in 2026
Medically reviewed by the Rite Aid Health Team · Last updated July 30, 2026
Semax is a synthetic peptide developed in Russia and studied for brain health and cognitive function. It is related to an ACTH fragment but does not share ACTH's hormonal activity.
Almost done
We sent the first email to .
A quick confirmation helps ensure future updates reach the right inbox.
We also sent a verification text. Reply YES to confirm your phone number.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Then your discount is reserved
Once you confirm, we reserve your discount and will notify you when peptide services launch.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Get 20% off your first compounded-peptide order
Join the early-access waitlist and we'll notify you the moment consultations and ordering open.
What is Semax?
Semax is a synthetic peptide derived from the ACTH 4-10 fragment, modified for stability. It was developed in Russia and is approved there for clinical use in conditions involving cognitive impairment and circulatory issues; it is not FDA-approved in the United States.
The peptide is best known as a nootropic — a compound studied for its effects on focus, memory, and mental performance. N-Acetyl Semax is a more stable variant with an acetyl group added to slow breakdown, often combined further with amino-acid additions in commercial formulations.
Benefits and uses
What the research shows — most of it from Russian clinical and preclinical research, with limited Western replication:
- Cognitive enhancement. Studied for improvements in focus, attention, and memory, particularly under conditions of mental fatigue.
- Neuroprotection. Investigated in the recovery period after ischemic events and in protecting neurons from stress.
- Recovery from cognitive fatigue. Used to support mental performance during demanding cognitive workloads.
- Mood and stress modulation. Effects attributed to its action on neurotransmitter systems.
The honest framing: the bulk of human evidence is Russian research, and rigorous Western clinical trials are limited. The nootropic following is large, but the Western evidence base is thinner than the enthusiasm suggests.
How it works
Semax increases brain-derived neurotrophic factor (BDNF), a protein central to neuronal growth, survival, and plasticity. It also modulates several neurotransmitter systems — including dopaminergic and serotonergic signaling — which is consistent with its reported effects on focus and mood.
Because it derives from ACTH 4-10 but lacks the hormonal portion of the molecule, it acts on the nervous system without triggering corticosteroid release.
Dosage and administration
Semax is most commonly administered intranasally (as a nasal spray or drops), which is the route used in its clinical history; subcutaneous injection is also used.
There is no FDA-approved Semax product and no official dosing guideline. Protocols vary by formulation and concentration, and N-Acetyl Semax is dosed differently from plain Semax. Dosing should be set by a prescribing provider.
For a peptide your clinician prescribed and an appropriate pharmacy prepared, use the peptide dosage calculator to convert a prescribed target dose into the right volume for your concentration.
Side effects and safety
Semax is generally reported to be well tolerated, with a long clinical-use history in Russia. Reported effects are mild — nasal irritation with intranasal use, and occasional changes in alertness.
Long-term safety data outside the Russian clinical record is limited. Anyone using Semax should work with a provider and establish a safety baseline.
How to get Semax in 2026
The FDA removed Semax from its Section 503A Category 2 list in April 2026.
On July 23 and 24, an FDA advisory committee recommended adding it to the Section 503A Bulks List. The committee considered cerebral ischemia, migraine, and trigeminal neuralgia.
The vote was advisory. It was not drug approval, and the FDA has not made a final decision. Current access rules remain unchanged.
Products sold online for research use are not approved for human use. Their identity, strength, and quality may be uncertain.
Almost done
We sent the first email to .
A quick confirmation helps ensure future updates reach the right inbox.
We also sent a verification text. Reply YES to confirm your phone number.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Then your discount is reserved
Once you confirm, we reserve your discount and will notify you when peptide services launch.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Get 20% off your first compounded-peptide order
Join the early-access waitlist and we'll notify you the moment consultations and ordering open.
Semax vs other nootropic peptides
Semax is often grouped with other research peptides used for brain and longevity goals. It is run alongside or compared with Epitalon, the longevity peptide studied for circadian and sleep regulation, and DSIP, studied for sleep and stress resilience.
For a broader protocol, compare Semax with other anti-aging and longevity peptides.
Blood work to track Semax
Semax doesn't have a single direct biomarker, so tracking focuses on safety:
- Comprehensive metabolic profile — liver enzymes and kidney function, the safety baseline for any peptide cycle.
Test before you start and again at 4–6 weeks.
Baseline tests before a peptide cycle
Check safety and response markers before starting. These tests help establish a baseline for liver, kidney, glucose, hormone, and recovery tracking.
References
For general education only — not medical advice or a treatment recommendation. Peptides are not a substitute for care from a licensed provider. Talk to a qualified healthcare professional before you start, stop, or change any peptide, medication, or supplement.
FAQ
Most commonly for cognitive enhancement — focus, memory, and recovery from mental fatigue — and for neuroprotection. The strongest evidence is from Russian clinical and preclinical research; Western trials are limited.
An FDA advisory committee recommended Semax for the Section 503A Bulks List in July 2026. The vote was not drug approval, and the FDA has not made a final decision. Research-only products are not approved for human use.
Semax is most often given intranasally, with subcutaneous injection as an alternative. There is no FDA-approved product or official dosing, and N-Acetyl Semax is dosed differently from plain Semax. Dosing should be set by a prescribing provider.
N-Acetyl Semax adds an acetyl group to the molecule, which slows its breakdown and is intended to extend its effect. It is a more stable variant of the same base peptide.
No. Semax derives from the ACTH 4-10 fragment but lacks the hormonal portion of the molecule, so it has no corticotropic activity — it acts on the nervous system without triggering adrenal hormone release.
Reported effects are generally mild, including nasal irritation with intranasal use. Long-term safety data outside the Russian clinical record is limited.